Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
71 2.7% |
 |
Eli Lilly and CompanyLLY |
83 0% |
 |
PfizerPFE |
53 1.9% |
 |
AstrazenecaAZN |
82 0% |
 |
AbbVieABBV |
77 1.3% |
Month over Month
Employee view on business outlook (0 - 100)
| Oct 2024 | 56 | |
| Sep 2024 | 57 | |
| Aug 2024 | 56 | |
| Jul 2024 | 56 |
How do employees feel about the future at Organon & Co.?
The Business Outlook at Organon & Co. is neutral, according to employees. The average rating, aggregated from the top review sites in the US, of 56 out of 100 is decent.
Analyzing Business Outlook, how is Organon & Co. performing compared to its industry peers?
Compared to its peers, Organon & Co. ranks in the 56th percentile when it comes to Business Outlook.
How has the business outlook at Organon & Co. changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at Organon & Co..
Why is it important to track the business outlook at Organon & Co.?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Organon & Co..
